As of the latest SEC filings, Ultragenyx Pharmaceutical Inc. (RARE) is held by 244 institutional funds. The largest fund shareholder is State Street(R) SPDR(R) S&P(R) Biotech ETF (XBI), holding an estimated $65,109,185.15 in market value, representing 0.88% of its portfolio.
Funds holding Ultragenyx Pharmaceutical Inc. (RARE)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- RARE
- CIK:
- 0001515673
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 0.88% | $65,109,185.15 | 3,107,837 | Mar 31, 2026 | May 28, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $61,500,191.50 | 2,935,570 | Mar 31, 2026 | May 28, 2026 |
|
VEXPX
VANGUARD EXPLORER FUND
|
MF | Vanguard | 0.22% | $47,075,040.36 | 1,906,644 | Apr 30, 2026 | Jun 26, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.03% | $44,306,400.80 | 2,114,864 | Mar 31, 2026 | May 28, 2026 |
|
VISGX
VANGUARD SMALL-CAP GROWTH INDEX FUND
|
ETF | Vanguard | 0.06% | $24,922,727.55 | 1,189,629 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.03% | $22,623,255.55 | 1,079,869 | Mar 31, 2026 | May 28, 2026 |
|
QLENX
AQR Long-Short Equity Fund
|
MF | Independent / Boutique | 0.21% | $16,999,688.95 | 811,441 | Mar 31, 2026 | May 22, 2026 |
|
VSEQX
VANGUARD STRATEGIC EQUITY FUND
|
MF | Vanguard | 0.16% | $16,396,496.55 | 782,649 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.18% | $14,251,991.70 | 680,286 | Mar 31, 2026 | May 28, 2026 |
|
FSAKX
Strategic Advisers U.S. Total Stock Fund
|
MF | Fidelity | 0.02% | $14,026,632.15 | 599,685 | Feb 28, 2026 | Apr 24, 2026 |
|
CFSIX
Touchstone Funds Group Trust-Touchstone Sands Capital Select Growth Fund
|
MF | Independent / Boutique | 0.71% | $13,627,786.45 | 650,491 | Mar 31, 2026 | May 29, 2026 |
|
IWP
iShares Russell Mid-Cap Growth ETF
|
ETF | BlackRock / iShares | 0.07% | $12,949,802.55 | 618,129 | Mar 31, 2026 | May 28, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.05% | $10,981,160.59 | 469,481 | Feb 28, 2026 | Apr 24, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.02% | $9,837,600.10 | 420,590 | Feb 28, 2026 | Apr 24, 2026 |
|
FSMDX
Fidelity Mid Cap Index Fund
|
MF | Fidelity | 0.02% | $8,431,758.45 | 341,505 | Apr 30, 2026 | Jun 26, 2026 |
|
IWF
iShares Russell 1000 Growth ETF
|
ETF | BlackRock / iShares | 0.01% | $7,953,185.65 | 379,627 | Mar 31, 2026 | May 22, 2026 |
|
-
Small Cap Core Fund
|
ETF | John Hancock | 0.38% | $7,495,982.76 | 303,604 | Apr 30, 2026 | Jun 25, 2026 |
|
IWR
iShares Russell Mid-Cap ETF
|
ETF | BlackRock / iShares | 0.02% | $7,369,916.70 | 351,786 | Mar 31, 2026 | May 28, 2026 |
|
FCTDX
Strategic Advisers Fidelity U.S. Total Stock Fund
|
MF | Fidelity | 0.00% | $6,426,379.11 | 274,749 | Feb 28, 2026 | Apr 24, 2026 |
|
TSMEX
Nuveen Quant Small/Mid Cap Equity Fund
|
MF | TIAA / Nuveen | 0.24% | $6,125,095.20 | 248,080 | Apr 30, 2026 | Jun 24, 2026 |
|
VHCIX
VANGUARD HEALTH CARE INDEX FUND
|
ETF | Vanguard | 0.03% | $6,106,871.71 | 261,089 | Feb 28, 2026 | Apr 28, 2026 |
|
AQMIX
AQR Managed Futures Strategy Fund
|
MF | Independent / Boutique | 0.17% | $5,122,547.35 | 244,513 | Mar 31, 2026 | May 22, 2026 |
|
VSTCX
VANGUARD STRATEGIC SMALL-CAP EQUITY FUND
|
MF | Vanguard | 0.20% | $4,959,933.45 | 236,751 | Mar 31, 2026 | May 28, 2026 |
|
PRJIX
T. Rowe Price New Horizons Fund, Inc.
|
MF | T. Rowe Price | 0.04% | $4,867,083.05 | 232,319 | Mar 31, 2026 | May 28, 2026 |
|
GWEIX
AMG GW&K Small Cap Core Fund
|
MF | Independent / Boutique | 0.68% | $4,616,269.65 | 220,347 | Mar 31, 2026 | Jun 1, 2026 |
Advertisement (320x50)